Skin Biopsy Market to Experience Excellent CAGR of 9.89% and Overwhelming Growth of USD 162.7 Million by 2030

Comments · 1545 Views

The study offers a complete overview of the global market for skin biopsies and, by looking at the market's historical growth trajectory, pinpoints key market-moving drivers.

Skin Biopsy Market Players And Analysis By Type, Device, Indication And End User - Forecast till 2030

A new analysis from Market Research Future (MRFR) projects that the global skin biopsies market research will grow at a CAGR of 9.89% between 2022 and 2030. The study offers a complete overview of the global market for skin biopsies and, by looking at the market's historical growth trajectory, pinpoints key market-moving drivers. Using these measures, the report provides a complete analysis of the skin biopsy market's anticipated growth trajectory over the course of the projection period. The study also includes a thorough analysis of the key industry drivers and inhibitors that are anticipated to restrain the market throughout the course of the anticipated timeframe.

The increasing incidence of skin cancer and the use of skin biopsy in skin cancer detection are the primary factors driving the global market for skin biopsies. Biopsy is frequently used to diagnose skin cancer, just like it is for any other type of cancer. Skin biopsy allows medical professionals to see the illness site up close and diagnose patients without being hampered by things like the patient's location or sympathy for their pain. Given that it has gotten easier to diagnose and treat skin cancer in developing regions in recent years due to the expanding accessibility of cutting-edge medical facilities, the rising awareness of skin cancer in emerging regions is likely to be a major driver for the global market for skin biopsies.

The global skin biopsies market is projected to be significantly influenced by the rising prevalence of other skin conditions and infections. Various skin disorders like psoriasis, dermatitis, and other pathogenic and environmental illnesses can also be diagnosed using skin biopsy. Over the projection period, the demand from the skin biopsy market is projected to be driven by the rising air pollution, which strains skin health and increases the likelihood that some infections may penetrate the skin.

Competitive Analysis

Leading global skin biopsy market players include Boston Scientific Corporation, BD, Devicor Medical Products Inc., Hologic Inc., Cardinal Health, Gallini Srl, DTR Medical Ltd., and Cook Medical.

Segmentation of skin biopsy market

The global skin biopsy market is segmented on the basis of type, device, indication, end user, and region.

On the basis of type, the global skin biopsy market is segmented into shave biopsy, punch biopsy, excisional biopsy, and incisional biopsy.

On the basis of devices, the skin biopsy market is segmented into needle-based biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles, and others.

On the basis of indication, the skin biopsy market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer, and others. The skin infection segment is further segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma, and melanoma.

On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.

Regional Analysis:

The global skin biopsy market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominates the global skin biopsy market on the back of the growing prevalence of skin cancer in the region, the growing availability of advanced anti-cancer medication and procedures, and the growing prevalence of skin diseases. According to the American Academy of Dermatology, one in four American is affected by skin disease of some kind. This is likely to drive the demand for skin biopsies at a rapid rate over the forecast period.

Europe holds the second largest share in the global skin biopsy market and is likely to remain a leading contributor over the forecast period due to the growing prevalence and awareness about skin cancer in the region. The easy availability of advanced diagnosis protocols in Europe is also likely to be a major driver for the Europe market for skin biopsy over the forecast period.

Over the course of the projection period, Asia Pacific is projected to play a bigger role in the global market for skin biopsies due to the region's increased awareness of skin conditions like skin cancer.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Comments